Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
28.48
Dollar change
-0.89
Percentage change
-3.03
%
IndexRUT P/E22.69 EPS (ttm)1.25 Insider Own1.17% Shs Outstand162.29M Perf Week-2.10%
Market Cap4.62B Forward P/E14.68 EPS next Y1.94 Insider Trans3.33% Shs Float160.39M Perf Month-0.18%
Enterprise Value5.65B PEG2.13 EPS next Q0.43 Inst Own101.13% Short Float2.90% Perf Quarter-10.64%
Income211.25M P/S0.86 EPS this Y7.86% Inst Trans7.50% Short Ratio2.78 Perf Half Y-11.66%
Sales5.37B P/B3.40 EPS next Y13.86% ROA6.28% Short Interest4.65M Perf YTD22.76%
Book/sh8.38 P/C23.25 EPS next 5Y10.64% ROE15.25% 52W High35.53 -19.84% Perf Year-12.26%
Cash/sh1.23 P/FCF19.17 EPS past 3/5Y16.65% - ROIC8.26% 52W Low21.39 33.15% Perf 3Y-12.37%
Dividend Est.- EV/EBITDA14.13 Sales past 3/5Y13.28% 16.69% Gross Margin18.50% Volatility2.73% 2.62% Perf 5Y157.27%
Dividend TTM- EV/Sales1.05 EPS Y/Y TTM5.03% Oper. Margin6.22% ATR (14)0.83 Perf 10Y196.67%
Dividend Ex-Date- Quick Ratio1.00 Sales Y/Y TTM17.06% Profit Margin3.93% RSI (14)46.85 Recom1.18
Dividend Gr. 3/5Y- - Current Ratio1.52 EPS Q/Q1.02% SMA20-0.33% Beta0.90 Target Price38.78
Payout0.00% Debt/Eq0.90 Sales Q/Q15.39% SMA50-2.25% Rel Volume0.97 Prev Close29.37
Employees6015 LT Debt/Eq0.88 EarningsJul 30 BMO SMA200-5.25% Avg Volume1.67M Price28.48
IPOAug 15, 1996 Option/ShortYes / Yes EPS/Sales Surpr.3.98% 4.86% Trades Volume1,625,978 Change-3.03%
Date Action Analyst Rating Change Price Target Change
Apr-30-25Upgrade UBS Neutral → Buy $40
Jan-23-25Upgrade Jefferies Hold → Buy $26 → $35
Jan-13-25Upgrade BofA Securities Neutral → Buy $26 → $33
Dec-05-24Initiated UBS Neutral $26
Nov-04-24Downgrade Goldman Buy → Neutral $27
Oct-31-24Downgrade Jefferies Buy → Hold $38 → $26
Oct-30-24Downgrade BofA Securities Buy → Neutral $43 → $29
Jul-16-24Initiated JMP Securities Mkt Outperform $36
Feb-27-23Resumed Jefferies Buy $38
Jul-19-21Upgrade Goldman Neutral → Buy $20 → $25
Aug-25-25 04:05PM
Aug-21-25 04:59AM
Aug-20-25 08:45AM
Aug-14-25 11:33PM
Aug-12-25 01:02AM
12:53AM Loading…
12:53AM
Aug-11-25 04:05PM
Aug-07-25 10:16AM
08:00AM
Aug-03-25 03:16PM
Jul-30-25 08:10AM
07:28AM
07:07AM
07:00AM
Jul-28-25 11:14PM
02:00PM Loading…
Jul-12-25 02:00PM
Jul-10-25 12:36AM
Jun-26-25 03:00PM
Jun-25-25 04:05PM
Jun-23-25 12:11AM
Jun-20-25 08:44AM
Jun-10-25 03:00PM
Jun-04-25 11:35PM
May-11-25 05:16PM
May-08-25 12:35AM
May-06-25 03:20PM
May-05-25 02:48PM
12:35AM
May-02-25 12:45PM
11:40AM
04:05PM Loading…
May-01-25 04:05PM
Apr-30-25 03:10AM
02:56AM
Apr-29-25 12:29PM
08:05AM
07:32AM
07:04AM
07:00AM
Apr-28-25 03:03AM
Apr-25-25 01:42PM
08:51AM
Apr-24-25 12:50PM
04:17AM
Apr-22-25 01:29PM
05:20AM
Apr-21-25 05:04AM
Apr-17-25 01:50PM
05:19AM
Apr-16-25 10:25AM
Apr-15-25 04:00AM
Apr-14-25 11:40AM
Apr-13-25 10:44AM
Apr-11-25 11:46AM
06:21AM
Apr-09-25 12:31PM
08:59AM
Apr-03-25 01:09PM
01:59AM
Apr-01-25 05:28AM
Mar-31-25 08:05AM
Mar-28-25 11:06AM
Mar-25-25 09:15AM
Mar-24-25 04:05PM
12:45PM
Mar-21-25 05:05AM
Mar-20-25 11:40AM
Mar-19-25 05:03AM
Mar-14-25 09:01AM
Mar-13-25 05:04AM
Mar-12-25 05:02AM
Mar-07-25 12:45PM
Mar-06-25 08:03AM
Mar-05-25 08:05AM
08:00AM
Mar-04-25 12:20PM
09:15AM
Feb-28-25 09:55AM
Feb-27-25 02:09AM
Feb-26-25 08:17AM
08:05AM
07:11AM
07:00AM
Feb-25-25 08:02AM
Feb-14-25 04:03AM
04:03AM
04:01AM
Feb-13-25 01:13PM
04:01AM
Feb-11-25 04:03AM
04:02AM
Feb-06-25 11:08AM
Feb-02-25 04:32PM
Jan-29-25 12:10PM
Jan-26-25 03:11AM
Jan-25-25 07:26AM
Jan-14-25 09:58AM
Jan-13-25 10:35AM
07:05AM
Dec-04-24 04:05PM
Nov-06-24 04:05PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wright Norman L.DirectorSep 09 '25Buy29.313,41199,97615,501Sep 10 04:18 PM
Pate R CarterDirectorAug 20 '25Buy27.1975020,39141,910Aug 21 06:26 PM
KRAEMER HARRY M JANSEN JRDirectorAug 20 '25Buy27.1536,000977,278375,390Aug 21 06:25 PM
SULLIVAN TIMOTHY PDirectorAug 21 '25Buy27.5120,000550,20049,229Aug 21 06:24 PM
GOLDING DAVID WDirectorAug 21 '25Buy27.621,00027,625116,525Aug 21 06:24 PM
Smyser CollinGC & Corporate SecretaryMay 19 '25Option Exercise0.0011,196089,715May 21 04:17 PM
Bavaro MichaelChief Human Resources OfficerFeb 28 '25Option Exercise25.4314,739374,78475,970Mar 03 05:52 PM
Bavaro MichaelChief Human Resources OfficerFeb 28 '25Sale33.2630,9961,030,84344,974Mar 03 05:52 PM
Bavaro MichaelOfficerFeb 28 '25Proposed Sale33.2330,9961,029,900Feb 28 03:41 PM
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '25Option Exercise0.0011,0870772,073Feb 24 08:13 PM
SHAPIRO MICHAEL H.Chief Financial OfficerFeb 17 '25Option Exercise0.003,6520260,487Feb 19 06:17 PM
KRAEMER HARRY M JANSEN JRDirectorNov 08 '24Buy22.5443,000969,031326,334Nov 13 05:27 PM
RADEMACHER JOHN CHARLESChief Executive OfficerOct 26 '24Option Exercise0.0031,2160627,615Oct 29 04:23 PM
SHAPIRO MICHAEL H.Chief Financial OfficerOct 21 '24Option Exercise0.0017,0880264,405Oct 23 05:59 PM